Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116961
Status:
COMPLETED
Last Update Posted:
2012-02-07
First Post:
2005-06-30
Brief Title:
Velcade Doxil and Dexamethasone VDd as First Line Therapy for Multiple Myeloma
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Organization Data
Organization:
University of Michigan Rogel Cancer Center
Class:
OTHER
Study ID:
UMCC 2004047
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Michigan Rogel Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Andrzej J Jakubowiak MD PhD
Old Organization:
University of Michigan Comprehensive Cancer Center